133 related articles for article (PubMed ID: 16778192)
1. Osteopontin is an oncogenic Vav1- but not wild-type Vav1-responsive gene: implications for fibroblast transformation.
Schapira V; Lazer G; Katzav S
Cancer Res; 2006 Jun; 66(12):6183-91. PubMed ID: 16778192
[TBL] [Abstract][Full Text] [Related]
2. The association of Sam68 with Vav1 contributes to tumorigenesis.
Lazer G; Pe'er L; Schapira V; Richard S; Katzav S
Cell Signal; 2007 Dec; 19(12):2479-86. PubMed ID: 17855053
[TBL] [Abstract][Full Text] [Related]
3. Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies.
Katzav S
Cancer Lett; 2007 Oct; 255(2):241-54. PubMed ID: 17590270
[TBL] [Abstract][Full Text] [Related]
4. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis.
Lazer G; Idelchuk Y; Schapira V; Pikarsky E; Katzav S
J Pathol; 2009 Sep; 219(1):25-34. PubMed ID: 19533802
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Vav1 induces Rac-dependent apoptosis via inhibition of Bcl-2 family proteins and collaborates with p53 deficiency to promote hematopoietic progenitor cell proliferation.
Gu Y; Siefring JE; Wang L; Chae HD; Bailey JR; Zheng Y
Oncogene; 2006 Jun; 25(28):3963-72. PubMed ID: 16474842
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of the MET oncogene.
Merlin S; Pietronave S; Locarno D; Valente G; Follenzi A; Prat M
Cancer Sci; 2009 Apr; 100(4):633-8. PubMed ID: 19175607
[TBL] [Abstract][Full Text] [Related]
7. Mutation of Vav1 adaptor region reveals a new oncogenic activation.
Razanadrakoto L; Cormier F; Laurienté V; Dondi E; Gardano L; Katzav S; Guittat L; Varin-Blank N
Oncotarget; 2015 Feb; 6(4):2524-37. PubMed ID: 25426554
[TBL] [Abstract][Full Text] [Related]
8. Vav1: a hematopoietic signal transduction molecule involved in human malignancies.
Katzav S
Int J Biochem Cell Biol; 2009 Jun; 41(6):1245-8. PubMed ID: 19100858
[TBL] [Abstract][Full Text] [Related]
9. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Behrend EI; Wilson SM; Denhardt DT
Anticancer Res; 1992; 12(1):43-7. PubMed ID: 1567180
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
[TBL] [Abstract][Full Text] [Related]
11. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
Nielsen C; Thastrup J; Bøttzauw T; Jäättelä M; Kallunki T
Cancer Res; 2007 Jan; 67(1):178-85. PubMed ID: 17210697
[TBL] [Abstract][Full Text] [Related]
12. The haematopoietic specific signal transducer Vav1 is expressed in a subset of human neuroblastomas.
Hornstein I; Pikarsky E; Groysman M; Amir G; Peylan-Ramu N; Katzav S
J Pathol; 2003 Apr; 199(4):526-33. PubMed ID: 12635144
[TBL] [Abstract][Full Text] [Related]
13. Vav1 regulates the migration and adhesion of dendritic cells.
Spurrell DR; Luckashenak NA; Minney DC; Chaplin A; Penninger JM; Liwski RS; Clements JL; West KA
J Immunol; 2009 Jul; 183(1):310-8. PubMed ID: 19542442
[TBL] [Abstract][Full Text] [Related]
14. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.
Behrend EI; Craig AM; Wilson SM; Denhardt DT; Chambers AF
Cancer Res; 1994 Feb; 54(3):832-7. PubMed ID: 8306346
[TBL] [Abstract][Full Text] [Related]
15. La(3+)-induced extracellular signal-regulated kinase (ERK) signaling via a metal-sensing mechanism linking proliferation and apoptosis in NIH 3T3 cells.
Yu S; Hu J; Yang X; Wang K; Qian ZM
Biochemistry; 2006 Sep; 45(37):11217-25. PubMed ID: 16964983
[TBL] [Abstract][Full Text] [Related]
16. The Ras-MAPK pathway downregulates Caveolin-1 in rodent fibroblast but not in human fibroblasts: implications in the resistance to oncogene-mediated transformation.
Sasai K; Kakumoto K; Hanafusa H; Akagi T
Oncogene; 2007 Jan; 26(3):449-55. PubMed ID: 16832346
[TBL] [Abstract][Full Text] [Related]
17. Distinct functions of Vav1 in JNK1 activation in Jurkat T cells versus non-haematopoietic cells.
Kaminski S; Del Pozo MA; Hipskind RA; Altman A; Villalba M
Scand J Immunol; 2004 Jun; 59(6):527-35. PubMed ID: 15182247
[TBL] [Abstract][Full Text] [Related]
18. The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation.
Conacci-Sorrell M; Kaplan A; Raveh S; Gavert N; Sakurai T; Ben-Ze'ev A
Cancer Res; 2005 Dec; 65(24):11605-12. PubMed ID: 16357171
[TBL] [Abstract][Full Text] [Related]
19. Dissecting the functional domain requirements of cortactin in invadopodia formation.
Webb BA; Jia L; Eves R; Mak AS
Eur J Cell Biol; 2007 Apr; 86(4):189-206. PubMed ID: 17343955
[TBL] [Abstract][Full Text] [Related]
20. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
